Gan&Lee Pharmaceuticals. Posted 266.5 Million Yuan Net Profit in First Three Quarters of 2023

Gan&Lee Pharmaceuticals. (甘李药业股份有限公司) (603087.SH) reported a net profit of 266.5 million yuan in the first three quarters of 2023, reversing a net loss of 413.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 54.1% year-on-year.

At the end of the reporting period, it had 10.8 billion yuan in total assets and 934.6 million yuan in total liabilities, with a liability-to-asset ratio of 8.6%.